SCHEMBL3578286

SCHEMBL3578286

CN1CCN(C(=O)C(C)(C)Oc2ccc(Br)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
ALDH1A1 P00352 7/20 0.53
LMNA P02545 4/20 0.51
MAPT P10636 3/20 0.51
ALOX15 P16050 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
POLB P06746 1/20 0.48
DUSP3 P51452 2/20 0.47
PTPN5 P54829 2/20 0.47
PTPN11 Q06124 2/20 0.47
KDM4E B2RXH2 2/20 0.47
TSHR P16473 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3572860 0.99 NPSR1 (0.56) NPSR1MEN1KMT2AALDH1A1LMNA
SCHEMBL3567407 0.88 NPSR1 (0.56) NPSR1MEN1KMT2AALDH1A1LMNA
SCHEMBL15134823 0.85 ALDH1A1 (0.71) NPSR1MEN1KMT2AALDH1A1LMNA
SCHEMBL22209153 0.80 ALDH1A1 (0.64) NPSR1MEN1KMT2AALDH1A1LMNA
SCHEMBL14829644 0.77 MDH1 (0.51) NPSR1MEN1KMT2AALDH1A1LMNA
SCHEMBL24597769 0.73 ALDH1A1 (0.71) NPSR1MEN1KMT2AALDH1A1LMNA
SCHEMBL25442326 0.73 ALDH1A1 (0.56) NPSR1MEN1KMT2AALDH1A1LMNA
SCHEMBL10244960 0.72 ALDH1A1 (0.70) NPSR1MEN1KMT2AALDH1A1LMNA
SCHEMBL1811163 0.72 PPARA (0.67) NPSR1MEN1KMT2AALDH1A1LMNA
SCHEMBL15912487 0.72 KMT2A (0.48) NPSR1MEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705023-B2 Indoles useful in the treatment of inflammation BIOLIPOX AB (SE) 2010-04-27 US disclosed
EP-1778632-B1 INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2008-08-20 EP disclosed
US-20070287715-A1 Indoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287715-A1 Indoles Useful in the Treatment of Inflammation PTGS1, IDO1, PTGES NPSR1 91/4885MEN1 3621/4885KMT2A 4007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.